{"id":"https://openalex.org/W2929809507","doi":"https://doi.org/10.5551/jat.48918","title":"Clinical Applications of a Novel Selective PPAR\u03b1 Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases","display_name":"Clinical Applications of a Novel Selective PPAR\u03b1 Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases","alternate_titles":[],"publication_year":2019,"publication_date":"2019-03-29","ids":{"openalex":"https://openalex.org/W2929809507","doi":"https://doi.org/10.5551/jat.48918","mag":"2929809507","pmid":"https://pubmed.ncbi.nlm.nih.gov/30930344","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6514171"},"language":"en","primary_location":{"id":"doi:10.5551/jat.48918","doi":"https://doi.org/10.5551/jat.48918","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.48918","pdf_url":"https://www.jstage.jst.go.jp/article/jat/26/5/26_48918/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2929809507"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/jat/26/5/26_48918/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089216722","display_name":"Shizuya Yamashita","orcid":"https://orcid.org/0000-0001-6645-4185","observed_orcids":["https://orcid.org/0000-0001-6645-4185"]},"institutions":[{"id":"https://openalex.org/I4405254471","display_name":"Rinku General Medical Center","ror":"https://ror.org/01v60bs72","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405254471"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shizuya Yamashita","raw_affiliation_strings":["Department of Cardiology, Rinku General Medical Center","Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine","Department of Community Medicine, Osaka University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Rinku General Medical Center","institution_ids":["https://openalex.org/I4405254471"]},{"raw_affiliation_string":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Department of Community Medicine, Osaka University Graduate School of Medicine","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024439275","display_name":"Daisaku Masuda","orcid":"https://orcid.org/0000-0002-0954-4042","observed_orcids":["https://orcid.org/0000-0002-0954-4042"]},"institutions":[{"id":"https://openalex.org/I4405254471","display_name":"Rinku General Medical Center","ror":"https://ror.org/01v60bs72","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405254471"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daisaku Masuda","raw_affiliation_strings":["Department of Cardiology, Rinku General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Rinku General Medical Center","institution_ids":["https://openalex.org/I4405254471"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109934217","display_name":"Y\u016bji Matsuzawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117281","display_name":"Sumitomo Hospital","ror":"https://ror.org/02m9ewz37","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210117281"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Matsuzawa","raw_affiliation_strings":["Sumitomo Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Hospital","institution_ids":["https://openalex.org/I4210117281"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5089216722"],"corresponding_institution_ids":["https://openalex.org/I4405254471","https://openalex.org/I98285908"],"apc_list":null,"apc_paid":null,"fwci":0.8138,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.65261814,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"26","issue":"5","first_page":"389","last_page":"402"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0333000011742115,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemafibrate","display_name":"pemafibrate","score":1.0},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.781000018119812},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.949999988079071},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.75},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5370000004768372},{"id":"https://openalex.org/keywords/liver-function","display_name":"liver function","score":0.6790000200271606},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7369999885559082},{"id":"https://openalex.org/keywords/statin-drug-interactions","display_name":"statin-drug interactions","score":0.7599999904632568},{"id":"https://openalex.org/keywords/biliary-excretion","display_name":"biliary excretion","score":0.8069999814033508},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.8936870098114014},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8519665002822876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6441321969032288},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6426594257354736},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.5777831673622131},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.49972081184387207},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.4985690116882324},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46430283784866333},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.4307061433792114},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4153795540332794},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3592877686023712},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.184705913066864},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.12337037920951843},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.05671370029449463}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001583","descriptor_name":"Benzoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002087","descriptor_name":"Butyrates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.5551/jat.48918","doi":"https://doi.org/10.5551/jat.48918","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.48918","pdf_url":"https://www.jstage.jst.go.jp/article/jat/26/5/26_48918/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},{"id":"pmid:30930344","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30930344","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of atherosclerosis and thrombosis","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6514171","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6514171/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Atheroscler Thromb","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.5551/jat.48918","doi":"https://doi.org/10.5551/jat.48918","is_oa":true,"landing_page_url":"https://doi.org/10.5551/jat.48918","pdf_url":"https://www.jstage.jst.go.jp/article/jat/26/5/26_48918/_pdf","source":{"id":"https://openalex.org/S140063188","display_name":"Journal of Atherosclerosis and Thrombosis","issn_l":"1340-3478","issn":["1340-3478","1880-3873"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310313348","host_organization_name":"Japan Atherosclerosis Society","host_organization_lineage":["https://openalex.org/P4310313348"],"host_organization_lineage_names":["Japan Atherosclerosis Society"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Atherosclerosis and Thrombosis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4710069038","display_name":"Development of transvenous liver-specific mesenchymal stem cell transplantation therapy by cell-modification","funder_award_id":"17H02100","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"},{"id":"https://openalex.org/F4320310465","display_name":"Takeda Pharmaceutical Company","ror":"https://ror.org/04hjbmv12"},{"id":"https://openalex.org/F4320316238","display_name":"Kowa Company","ror":"https://ror.org/009z2z347"},{"id":"https://openalex.org/F4320317302","display_name":"Boehringer Ingelheim Japan","ror":"https://ror.org/02r1d7x68"},{"id":"https://openalex.org/F4320333996","display_name":"Amgen Astellas Biopharma","ror":null},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2929809507.pdf","grobid_xml":"https://content.openalex.org/works/W2929809507.grobid-xml"},"referenced_works_count":74,"referenced_works":["https://openalex.org/W65377277","https://openalex.org/W252161948","https://openalex.org/W1519335354","https://openalex.org/W1604969668","https://openalex.org/W1615613652","https://openalex.org/W1963533730","https://openalex.org/W1966550462","https://openalex.org/W1967308016","https://openalex.org/W1975936284","https://openalex.org/W1977666051","https://openalex.org/W1977704640","https://openalex.org/W1978805605","https://openalex.org/W1984913749","https://openalex.org/W2003036735","https://openalex.org/W2051583212","https://openalex.org/W2054851194","https://openalex.org/W2057906503","https://openalex.org/W2064473980","https://openalex.org/W2066092624","https://openalex.org/W2080361134","https://openalex.org/W2084934089","https://openalex.org/W2086602774","https://openalex.org/W2089035720","https://openalex.org/W2096210401","https://openalex.org/W2096449975","https://openalex.org/W2109429564","https://openalex.org/W2116775019","https://openalex.org/W2117378685","https://openalex.org/W2130906973","https://openalex.org/W2132198142","https://openalex.org/W2137489898","https://openalex.org/W2139318977","https://openalex.org/W2143889573","https://openalex.org/W2144259092","https://openalex.org/W2149433053","https://openalex.org/W2164089346","https://openalex.org/W2164324917","https://openalex.org/W2198678228","https://openalex.org/W2200285648","https://openalex.org/W2247997571","https://openalex.org/W2253407701","https://openalex.org/W2280192011","https://openalex.org/W2291598045","https://openalex.org/W2317994055","https://openalex.org/W2325344315","https://openalex.org/W2328529137","https://openalex.org/W2341665659","https://openalex.org/W2400712338","https://openalex.org/W2554722168","https://openalex.org/W2574726211","https://openalex.org/W2586612408","https://openalex.org/W2588037944","https://openalex.org/W2592180590","https://openalex.org/W2599479486","https://openalex.org/W2744310085","https://openalex.org/W2755428798","https://openalex.org/W2762341782","https://openalex.org/W2765263832","https://openalex.org/W2782064714","https://openalex.org/W2791151548","https://openalex.org/W2794847782","https://openalex.org/W2796005123","https://openalex.org/W2806197988","https://openalex.org/W2806228696","https://openalex.org/W2806385410","https://openalex.org/W2807268215","https://openalex.org/W2807422626","https://openalex.org/W2809788304","https://openalex.org/W2811176080","https://openalex.org/W2883588014","https://openalex.org/W2886508110","https://openalex.org/W2892632954","https://openalex.org/W2903550451","https://openalex.org/W2913672551"],"related_works":["https://openalex.org/W3002287592","https://openalex.org/W4368377524","https://openalex.org/W2762341782","https://openalex.org/W3119690882","https://openalex.org/W2765263832","https://openalex.org/W2977485959","https://openalex.org/W2606681350","https://openalex.org/W2144259092","https://openalex.org/W2744310085","https://openalex.org/W4211182087"],"abstract_inverted_index":{"Fasting":[0],"and":[1,22,48,84,102,118,128,142,203,223,244],"postprandial":[2],"hypertriglyceridemia":[3],"is":[4,185,205,261],"a":[5,79],"risk":[6],"factor":[7],"for":[8,32,62,99,227,229,255],"atherosclerotic":[9],"cardiovascular":[10],"diseases":[11],"(ASCVD).":[12],"Fibrates":[13],"have":[14,29,58],"been":[15,87],"used":[16,167,195,226],"to":[17,146,220,234],"treat":[18],"dyslipidemia,":[19],"particularly":[20],"hypertriglyceridemia,":[21],"low":[23,30],"HDL-cholesterol":[24],"(HDL-C).":[25],"However,":[26],"conventional":[27,177,221],"fibrates":[28,57,121,178,222],"selectivity":[31],"peroxisome":[33],"proliferator-activated":[34],"receptor":[35],"(PPAR)\u03b1.":[36],"Fibrates'":[37],"clinical":[38,54],"use":[39,235],"causes":[40],"side":[41],"effects":[42,112],"such":[43],"as":[44],"worsening":[45],"liver":[46,124,138],"function":[47,125,131,139,202],"elevating":[49],"the":[50,70,73,110,152,176,188,265,268],"creatinine":[51,149],"level.":[52],"Large-scale":[53],"trials":[55,105],"of":[56,64,72,82,113,175],"shown":[59],"negative":[60],"results":[61],"prevention":[63],"ASCVD.":[65],"To":[66],"overcome":[67],"these":[68],"issues,":[69],"concept":[71],"selective":[74],"PPAR\u03b1":[75],"modulator":[76],"(SPPARM\u03b1),":[77],"with":[78,169,199,246,257],"superior":[80,111,216],"balance":[81,218],"efficacy":[83,101],"safety,":[85],"has":[86,215],"proposed.":[88],"A":[89,249],"SPPARM\u03b1,":[90,213],"pemafibrate":[91,114,135,184,254,272],"(K-877),":[92],"was":[93,143,166,232],"synthesized":[94],"by":[95],"Kowa":[96],"Company,":[97],"Ltd.":[98],"better":[100],"safety.":[103],"Clinical":[104],"conducted":[106],"in":[107,197,208,262],"Japan":[108],"confirmed":[109],"on":[115,271],"triglyceride":[116],"reduction":[117],"HDL-C":[119],"elevation.Conventional":[120],"showed":[122],"elevated":[123],"test":[126,132,140],"values":[127,141],"worsened":[129],"kidney":[130],"values,":[133],"while":[134],"demonstrated":[136],"improved":[137],"less":[144],"likely":[145],"increase":[147,207],"serum":[148],"or":[150],"decrease":[151],"estimated":[153],"glomerular":[154],"filtration":[155],"rate.":[156],"There":[157],"were":[158],"extremely":[159],"few":[160],"drug":[161],"interactions":[162],"even":[163,196],"when":[164],"it":[165,191,231],"concomitantly":[168],"various":[170],"statins.":[171],"Furthermore,":[172],"unlike":[173],"many":[174],"that":[179],"are":[180,241],"renal":[181,201,247],"excretory-type":[182],"drugs,":[183],"excreted":[186],"into":[187],"bile,":[189],"so":[190],"can":[192,224],"be":[193,225,274],"safely":[194],"patients":[198,228,256],"impaired":[200],"there":[204],"no":[206],"its":[209],"blood":[210],"concentration.This":[211],"novel":[212],"pemafibrate,":[214],"benefit-risk":[217],"compared":[219],"whom":[230],"difficult":[233],"existing":[236],"fibrates,":[237],"including":[238],"those":[239,245],"who":[240],"taking":[242],"statins":[243],"dysfunction.":[248],"large-scale":[250],"trial":[251],"PROMINENT":[252],"using":[253],"type":[258],"2":[259],"diabetes":[260],"progress.":[263],"In":[264],"current":[266],"review,":[267],"latest":[269],"data":[270],"will":[273],"summarized.":[275]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2929809507","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-04-11T00:00:00"}
